LIROH - Liraglutide for Obesity in HIV (opens ClinicalTrials.gov)
- Sponsor
- Brigham and Women's Hospital
- Enrolment
- 40
- Started
- 2024-05-02
- Last update
- 2024-05-31
Conditions: Obesity, HIV Infections
Interventions: Liraglutide
Research discovery
— registered studies
Verify this search on the official site ↗ · fetched Nov 5, 2026, 2:21 AM UTC
Status on this page
A registered trial is a plan, not a result. “Results posted” means the sponsor uploaded summary results to the registry; it says nothing about whether the treatment worked.
Conditions: Obesity, HIV Infections
Interventions: Liraglutide
Conditions: Obesity, Overweight
Interventions: Tirzepatide, Placebo, Liraglutide
Conditions: Diabetes Mellitus, Type 2
Interventions: IDegLira, Premixed insulin
Conditions: Diabetes Mellitus, Type 2
Interventions: Insulin degludec and liraglutide (IDegLira)
Conditions: Parkinson Disease
Interventions: Liraglutide, Placebo
Conditions: Brain Death
Interventions: Liraglutide
Conditions: Type 1 Diabetes
Interventions: Victoza, Placebo, Dapagliflozin 10mg Tab
Conditions: Type 1 Diabetes
Interventions: Liraglutide / Semaglutide, Dapagliflozin, Liraglutide or Semaglutide / Dapagliflozin, Liraglutide or Semaglutide / Dapagliflozin plus intensive weight loss nutrition…
Conditions: Weight Loss, Diabetes Mellitus, Type 2, Quality of Life, Safety Issues
Interventions: GLP-1 receptor agonist
Conditions: Diabetes Mellitus, Type 2
Interventions: Empagliflozin, Liraglutide
Conditions: Diabetes, Diabetes Mellitus, Type 2
Interventions: liraglutide, placebo
Conditions: Diabetes Mellitus, Type 2
Interventions: GLP-1 receptor agonist
Conditions: Type 1 Diabetes Mellitus
Interventions: Dapagliflozin, Insulin, Liraglutide, Dapagliflozin placebo
Conditions: Panhypopituitarism, Craniopharyngioma, Hypothalamic Obesity
Interventions: Saxenda
Conditions: Type 1 Diabetes
Interventions: Liraglutide 1.8mg, Placebo
Conditions: Weight Loss, Bariatric Surgery Candidate, Obesity, Morbid
Interventions: Liraglutide injection
Conditions: Type 1 Diabetes
Interventions: Liraglutide, Placebo
Conditions: Diabetes, Healthy
Interventions: liraglutide
Conditions: Sleep Apnea, Obstructive
Interventions: Liraglutide (Saxenda) 6Mg/Ml Inj Pen 3Ml, Continuous positive airway pressure treatment, Liraglutide and CPAP
Conditions: Diabetes Mellitus, Type 2
Interventions: Insulin Degludec / Liraglutide Injectable Product, Insulin Glargine